CN113358733A - Method for detecting new biosynthesis pathway in cell - Google Patents
Method for detecting new biosynthesis pathway in cell Download PDFInfo
- Publication number
- CN113358733A CN113358733A CN202110682856.1A CN202110682856A CN113358733A CN 113358733 A CN113358733 A CN 113358733A CN 202110682856 A CN202110682856 A CN 202110682856A CN 113358733 A CN113358733 A CN 113358733A
- Authority
- CN
- China
- Prior art keywords
- sample slice
- solution
- isotope
- sample
- slice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
Abstract
The invention discloses a method for detecting a new biosynthesis pathway in a cell, which comprises the following steps: s1, preparing a sample slice, and injecting an isotope solution into the sample slice to generate a target sample slice; s2, carrying out MS detection on the target sample slice to obtain the metabolic pathway of the chemical substances in the sample slice, wherein S2 comprises the following steps: s21, performing MS detection on the target sample slice to obtain MS data corresponding to the target sample slice and analyzing the MS data; s22, obtaining a metabolic pathway of the chemical substances in the sample slice according to the analysis result of the MS data; the invention can standardize the ion intensity value of the metabolite marked with the isotope, avoid the poor comparability among different samples, and ensure the effective isotope tracking so as to obtain the complete synthetic path of the chemical substance.
Description
Technical Field
The invention relates to the technical field of human biosynthesis, in particular to a method for detecting a novel intracellular biosynthesis pathway.
Background
With the development of science and technology, the detection of biosynthesis pathways is more and more important, especially new biosynthesis pathways in cells, so that researchers can more deeply understand the synthesis of chemical substances, and thus, some problems in the biological field can be overcome.
At present, most of researches on synthesis paths are based on isotope tracking, and different compounds generated by isotopes know the biosynthesis paths, so that isotope tracking processing is needed to be researched by technicians in the field to ensure the accuracy of the biosynthesis paths, but in the prior art, MS calculation related to the isotope tracking process is calculated through original data, the accuracy of the MS calculation is influenced, and effective isotope tracking cannot be ensured to obtain the complete synthesis paths of chemical substances.
Disclosure of Invention
In order to solve the problems in the prior art, the ion intensity value of the metabolite of the marked isotope can be standardized, the poor comparability among different samples is avoided, and the effective isotope tracking is ensured so as to obtain a complete synthetic path of chemical substances; the embodiment of the invention provides a method for detecting a novel biosynthesis pathway in a cell, which comprises the following steps:
s1, preparing a sample slice, and injecting an isotope solution into the sample slice to generate a target sample slice;
s2, carrying out MS detection on the target sample slice to obtain a metabolic pathway of the chemical substances in the sample slice;
wherein, S2 includes the following steps:
s21, performing MS detection on the target sample slice to obtain MS data corresponding to the target sample slice and analyzing the MS data;
s22, obtaining the metabolic pathway of the chemical substances in the sample slice according to the analysis result of the MS data, wherein the analysis result of the MS data adopts the following formula:
wherein the content of the first and second substances,
is marked by13The ratio of the metabolites of C is such that,
means not marked13Ratio of C metabolites.
Further, S1 further includes the following steps of determining the sample slice:
taking a brain tissue sample of a target subject;
placing the brain tissue sample in a slicing solution for culture treatment, wherein the slicing solution comprises the following components: sucrose, NaCl, NaHCO3、MgCl2Glucose, KCl and NaH2PO4；
And slicing the cultured brain tissue sample to obtain the sample slice.
Further, sucrose, NaCl, NaHCO3、MgCl2Glucose, KCl and NaH2PO4Comprises the following chemical components in percentage by weight: 200mM, 30mM, 26mM, 1mM, 10mM, 4.5mM and 1.2mM, the contents being in order of chemical composition.
Further, the step of S1 further includes the steps of determining the target sample slice: preparing a preformed solution, wherein the preformed solution is a diluted solution of a labeled isotope histidine;
under the condition of room temperature, the sample slice is incubated in the prepared solution for a preset time;
cleaning the incubated sample slice, and obtaining a single neuron sample on the cleaned sample slice;
and injecting a preset isotope solution into the single neuron sample to obtain the target sample slice.
Further, the isotope may be used13C。
Further, before analyzing the MS data in S21, the method further includes: carrying out calibration processing on a UCA numerical curve in MS data, wherein the calibration processing comprises the following steps:
preparing a plurality of calibration solutions with different concentrations according to a standard sample, wherein each calibration solution is an intracellular solution;
and sequentially calibrating the UCA numerical curve according to the concentration based on each calibration solution.
Further, the chemical composition of the intracellular solution is: potassium gluconate, NaCl, EGTA, HEPES, CaCl2、CsOH、MgCl2Na-ATP and Na-GTP.
Further, potassium gluconate, NaCl, EGTA, HEPES, CaCl2、CsOH、MgCl2The contents of Na-ATP and Na-GTP are respectively as follows: 130mM, 6mM, 10mM, 1mM, 4mM, 1mM, 2mM, and 0.2mM, wherein the order of contents is in order of chemical composition.
Further, the diluted solution of isotopic histidine was subjected to dilution and washing treatment by cerebrospinal fluid.
Further, in S22, obtaining a metabolic pathway of the chemical substance in the sample slice according to the analysis result of the MS data, further comprising the steps of:
comparing the increment corresponding to the metabolite ion strength of the labeled isotope with a preset threshold, wherein the increment is an increment value of the metabolite ion strength in percentage of the mass number of the substance;
and when the corresponding increment of the ion intensity of the metabolite of the labeled isotope is larger than the threshold value, tracking the metabolic path formed by the chemical substance of the labeled isotope.
The method for detecting the new biosynthesis pathway in the cell has the following technical effects:
according to the invention, based on a formula of MS data, an accurate ion intensity value of a metabolite to be detected is obtained during isotope tracking, and then a proportion change value between the metabolite marked with the isotope and the metabolite not marked with the isotope is obtained according to the ion intensity value of the metabolite to be detected, so that a complete synthetic path of a chemical substance can be effectively obtained according to the tracked isotope, an accurate chemical substance is obtained according to the synthetic path of the chemical substance, the inaccuracy of a detection result is avoided, and the judgment of the chemical substance in the cell is further influenced, and a researcher can predict the metabolic state of the cell according to the chemical substance in the cell.
Drawings
In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings needed to be used in the description of the embodiments will be briefly introduced below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art to obtain other drawings based on these drawings without creative efforts.
FIG. 1 is a flow chart of a method for detecting a novel biosynthetic pathway in a cell according to an embodiment of the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without any inventive step based on the embodiments of the present invention, are within the scope of the present invention.
As shown in FIG. 1, the present example provides a method for detecting a novel biosynthetic pathway in a cell, the method comprising the steps of:
s1, preparing a sample slice, and injecting an isotope solution into the sample slice to generate a target sample slice;
s2, carrying out MS detection on the target sample slice to obtain a metabolic pathway of the chemical substances in the sample slice;
wherein, S2 includes the following steps:
s21, performing MS detection on the target sample slice to obtain MS data corresponding to the target sample slice and analyzing the MS data;
s22, obtaining the metabolic pathway of the chemical substances in the sample slice according to the analysis result of the MS data, wherein the analysis result of the MS data adopts the following formula:
wherein the content of the first and second substances,
is marked by13The ratio of the metabolites of C is such that,
means not marked13Ratio of C metabolites.
Specifically, S1 further includes the following steps of determining the sample slice:
taking a brain tissue sample of a target subject;
placing the brain tissue sample in a slicing solution for culture treatment, wherein the slicing solution comprises the following components: sucrose, NaCl, NaHCO3、MgCl2Glucose, KCl and NaH2PO4；
And slicing the cultured brain tissue sample to obtain the sample slice.
Further, the target object refers to an experimental object to be subjected to the metabolic pathway assay of a compound, for example, an experimental mouse or an experimental monkey, etc., wherein the target object is in a normal biologically-recognized dead state.
Further, sucrose, NaCl, NaHCO3、MgCl2Glucose, KCl and NaH2PO4Comprises the following chemical components in percentage by weight: 200mM, 30mM, 26mM, 1mM, 10mM, 4.5mM and 1.2mM, the content sequence is ordered according to the sequence of chemical components, which can facilitate the tracing of isotopes of different compounds for cultured sample slices and improve the accuracy of isotope analysis.
Further, the slicing solution corresponds to a temperature of 0-10 ℃.
Further, the slicing solution corresponds to a pH of 7.4.
Further, the specimen slice is a coronal slice of 250 μm.
Specifically, the step of S1 further includes the steps of determining the target specimen slice:
preparing a preformed solution, wherein the preformed solution is a diluted solution of a labeled isotope histidine;
under the condition of room temperature, the sample slice is incubated in the prepared solution for a preset time;
cleaning the incubated sample slice, and obtaining a single neuron sample on the cleaned sample slice;
and injecting a preset isotope solution into the single neuron sample to obtain the target sample slice.
Specifically, dilute the diluted solution of isotope histidine through cerebrospinal fluid, wherein, the cerebrospinal fluid still is used for washing processing, can avoid the introduction of other chemicals on the one hand, leads to the inaccuracy that MS detected, and on the other hand adopts cerebrospinal fluid reduction cost to can cyclic utilization cerebrospinal fluid.
Further, the content of the pre-prepared solution was 4 mg/ml.
Further, the preset time is 1 hour.
Further, the isotope may be used13C, in some embodiments, the isotope may be used15N。
Specifically, S22 is preceded by:
the MS data corresponding to the target sample slice is preprocessed, wherein the preprocessing refers to the fact that the metabolite ion strength and the total ion current (I/TIC) in the MS data are compared to realize standardization, so that the difference of the total ion current of mass spectrum detection signals of different samples can be avoided, comparability among the samples is poor, and the comparability of the signals among the samples and the accuracy of analysis results are improved; wherein the normalized error value ranges from 10 ppm.
Specifically, before analyzing the MS data in S21, the method further includes: carrying out calibration processing on a UCA numerical curve in MS data, wherein the calibration processing comprises the following steps:
preparing a plurality of calibration solutions with different concentrations according to a standard sample, wherein each calibration solution is an intracellular solution;
and sequentially calibrating the UCA numerical curve according to the concentration based on each calibration solution.
Specifically, the chemical composition of the intracellular solution is: potassium gluconate, NaCl, EGTA, HEPES, CaCl2、CsOH、MgCl2Na-ATP and Na-GTP.
Further, potassium gluconate, NaCl, EGTA, HEPES, CaCl2、CsOH、MgCl2The contents of Na-ATP and Na-GTP are respectively as follows: 130mM, 6mM, 10mM, 1mM, 4mM, 1mM, 2mM, and 0.2mM, wherein the order of contents is in order of chemical composition.
Further, the intracellular solution corresponds to a PH of 7.4.
Further, the concentrations of the calibration solutions were 2, 20, 200 and 400 μ M, respectively.
Further, in S22, obtaining a metabolic pathway of the chemical substance in the sample slice according to the analysis result of the MS data, further comprising the steps of:
comparing the increment corresponding to the metabolite ion strength of the labeled isotope with a preset threshold, wherein the increment is an increment value of the metabolite ion strength in percentage of the mass number of the substance;
and when the corresponding increment of the ion intensity of the metabolite of the labeled isotope is larger than the threshold value, tracking the metabolic path formed by the chemical substance of the labeled isotope.
In one specific example, data from blood and cerebrospinal fluid with and without isotope are compared as shown in Table 1.
TABLE 1
In a specific example, the results of the MS analysis data analysis corresponding to the target sample sections incubated with and without the isotope are compared, as shown in table 2.
TABLE 2
From the data in tables 1 and 2, it can be observed that the ratio of histidine, urocanic acid and glutamic acid is significantly different when the sample sections are incubated and not incubated, and the ratio can be traced by isotope, and the product of histidine, urocanic acid and glutamic acid is the metabolite synthesis path, so that the metabolite synthesis path can be obviously characterized.
The method for detecting a new intracellular biosynthesis pathway provided by the embodiment can be based on a formula of MS data, so that when an isotope is tracked, an accurate ion intensity value of a metabolite to be detected is obtained, and then a ratio change value between the metabolite with the isotope labeled and the metabolite without the isotope labeled is obtained according to the ion intensity value of the metabolite to be detected, a complete synthesis pathway of a chemical substance can be effectively obtained according to the tracked isotope, so that an accurate chemical substance is obtained according to the synthesis pathway of the chemical substance, the inaccuracy of a detection result is avoided, and the judgment of the chemical substance in the cell is further influenced, and a researcher can predict the metabolic state of the cell according to the chemical substance in the cell.
Claims (10)
1. A method for detecting a new biosynthetic pathway in a cell, comprising the steps of:
s1, preparing a sample slice, and injecting an isotope solution into the sample slice to generate a target sample slice;
s2, carrying out MS detection on the target sample slice to obtain a metabolic pathway of the chemical substances in the sample slice;
wherein, S2 includes the following steps:
s21, performing MS detection on the target sample slice to obtain MS data corresponding to the target sample slice and analyzing the MS data;
s22, obtaining the metabolic pathway of the chemical substances in the sample slice according to the analysis result of the MS data, wherein the analysis result of the MS data adopts the following formula:
wherein the content of the first and second substances,
is marked by13The ratio of the metabolites of C is such that,
means not marked13Ratio of C metabolites.
2. The method for exploring a new intracellular biosynthetic pathway of claim 1, wherein S1 further comprises the steps of:
taking a brain tissue sample of a target subject;
placing the brain tissue sample in a slicing solution for culture treatment, wherein the slicing solution comprises the following components: sucrose, NaCl, NaHCO3、MgCl2Glucose, KCl and NaH2PO4；
And slicing the cultured brain tissue sample to obtain the sample slice.
3. The method for detecting a novel biosynthetic pathway according to claim 2, wherein sucrose, NaCl, NaHCO is used3、MgCl2Glucose, KCl and NaH2PO4Comprises the following chemical components in percentage by weight: 200mM, 30mM, 26mM, 1mM, 10mM, 4.5mM and 1.2mM, the contents being in order of chemical composition.
4. The method for detecting a new biosynthetic pathway of cells according to claim 1, wherein the step of S1 further comprises the steps of:
preparing a preformed solution, wherein the preformed solution is a diluted solution of a labeled isotope histidine;
under the condition of room temperature, the sample slice is incubated in the prepared solution for a preset time;
cleaning the incubated sample slice, and obtaining a single neuron sample on the cleaned sample slice;
and injecting a preset isotope solution into the single neuron sample to obtain the target sample slice.
5. The method for detecting a new biosynthesis pathway in a cell according to claim 1, wherein the isotope is selected from the group consisting of13C。
6. The method for detecting a novel intracellular biosynthetic pathway of claim 1, further comprising, prior to analyzing the MS data in S21: carrying out calibration processing on a UCA numerical curve in MS data, wherein the calibration processing comprises the following steps:
preparing a plurality of calibration solutions with different concentrations according to a standard sample, wherein each calibration solution is an intracellular solution;
and sequentially calibrating the UCA numerical curve according to the concentration based on each calibration solution.
7. The method for exploring a new intracellular biosynthetic pathway of claim 6, wherein the chemical composition of said intracellular solution is: potassium gluconate, NaCl, EGTA, HEPES, CaCl2、CsOH、MgCl2Na-ATP and Na-GTP.
8. The method for detecting a novel biosynthetic pathway according to claim 7, wherein potassium gluconate, NaCl, EGTA, HEPES, CaCl2、CsOH、MgCl2The contents of Na-ATP and Na-GTP are respectively as follows: 130mM, 6mM, 10mM,1mM, 4mM, 1mM, 2mM and 0.2mM, wherein the content is ordered according to the order of chemical components.
9. The method for detecting a new biosynthesis pathway in a cell according to claim 1, wherein the diluted solution of isotopic histidine is subjected to a dilution and washing treatment by cerebrospinal fluid.
10. The method for detecting a novel intracellular biosynthesis pathway according to claim 1, wherein in S22, the metabolic pathway of a chemical substance in a specimen slice is obtained based on the result of analysis of the MS data, and further comprising the steps of:
comparing the increment corresponding to the metabolite ion strength of the labeled isotope with a preset threshold, wherein the increment is an increment value of the metabolite ion strength in percentage of the mass number of the substance;
and when the corresponding increment of the ion intensity of the metabolite of the labeled isotope is larger than the threshold value, tracking the metabolic path formed by the chemical substance of the labeled isotope.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110682856.1A CN113358733B (en) | 2021-06-17 | 2021-06-17 | Method for detecting new biosynthesis pathway in cell |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110682856.1A CN113358733B (en) | 2021-06-17 | 2021-06-17 | Method for detecting new biosynthesis pathway in cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113358733A true CN113358733A (en) | 2021-09-07 |
| CN113358733B CN113358733B (en) | 2023-01-03 |
Family
ID=77535248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110682856.1A Active CN113358733B (en) | 2021-06-17 | 2021-06-17 | Method for detecting new biosynthesis pathway in cell |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113358733B (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030180710A1 (en) * | 2002-03-22 | 2003-09-25 | Lee Wai-Nang Paul | Method of enhancing the efficiency of a pharmaceutical business |
| US20060105322A1 (en) * | 2003-06-30 | 2006-05-18 | Ajinomoto Co., Inc. | Intracellular metabolic flux analysis method using substrate labeled with isotope |
| US20150330969A1 (en) * | 2014-05-14 | 2015-11-19 | Max-Delbrueck-Centrum Fuer Molekulare Medizin | Short term isotope pulse labeling method for analysing metabolic products in biological samples |
| CN105527350A (en) * | 2014-10-27 | 2016-04-27 | 中国科学院大连化学物理研究所 | Intracellular amino acid metabolic profiling analysis method |
| CN106959345A (en) * | 2017-03-27 | 2017-07-18 | 上海谱领生物科技有限公司 | A kind of full Isotopic Internal Standard mass spectrum quantitative approach of neurotransmitter metabolite |
| CN108931587A (en) * | 2018-04-18 | 2018-12-04 | 湖州市中心医院 | A kind of method of the diagnostic biomarkers of quantitative detection NSCLC |
-
2021
- 2021-06-17 CN CN202110682856.1A patent/CN113358733B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030180710A1 (en) * | 2002-03-22 | 2003-09-25 | Lee Wai-Nang Paul | Method of enhancing the efficiency of a pharmaceutical business |
| US20060105322A1 (en) * | 2003-06-30 | 2006-05-18 | Ajinomoto Co., Inc. | Intracellular metabolic flux analysis method using substrate labeled with isotope |
| US20150330969A1 (en) * | 2014-05-14 | 2015-11-19 | Max-Delbrueck-Centrum Fuer Molekulare Medizin | Short term isotope pulse labeling method for analysing metabolic products in biological samples |
| CN105527350A (en) * | 2014-10-27 | 2016-04-27 | 中国科学院大连化学物理研究所 | Intracellular amino acid metabolic profiling analysis method |
| CN106959345A (en) * | 2017-03-27 | 2017-07-18 | 上海谱领生物科技有限公司 | A kind of full Isotopic Internal Standard mass spectrum quantitative approach of neurotransmitter metabolite |
| CN108931587A (en) * | 2018-04-18 | 2018-12-04 | 湖州市中心医院 | A kind of method of the diagnostic biomarkers of quantitative detection NSCLC |
Non-Patent Citations (1)
| Title |
|---|
| 王宁: "适量UV照射对脑内谷氨酸合成新通路的影响", 《中国博士学位论文全文数据库》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113358733B (en) | 2023-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Spichiger-Keller | Chemical sensors and biosensors for medical and biological applications | |
| Trivedi et al. | Potentiometric biosensor for urea determination in milk | |
| Zhang et al. | Rapid and wide-range determination of Cd (II), Pb (II), Cu (II) and Hg (II) in fish tissues using light addressable potentiometric sensor | |
| JP2016513259A (en) | Method for identifying bacterial species in a biological sample by gas chromatography mass spectrometry (GC / MS) | |
| CN111638303A (en) | Distinguish metal ion Al3+And Zn2+Method (2) | |
| Ciosek et al. | Potentiometric electronic tongue based on integrated array of microelectrodes | |
| EP3168605B1 (en) | Buffer system and method of using the buffer system to measure total alkaloid in tobacco or tobacco products through continuous flow | |
| Zoerner et al. | Human Sweat Analysis Using a Portable Device Based on a Screen‐printed Electrolyte Sensor | |
| JP2016025860A (en) | Method for monitoring cell culture | |
| Wolf et al. | Evaluation of five clinical chemistry analyzers for use in health assessment in sea turtles | |
| CN102759526B (en) | Method for quantitative detection of mercury ions through gold label silver stain and kit thereof | |
| Qian et al. | Analysis and Diagnosis of Hemolytic Specimens by AU5800 Biochemical Analyzer Combined With AI Technology | |
| Cai et al. | Determination of Chinese Angelica honey adulterated with rice syrup by an electrochemical sensor and chemometrics | |
| Widdowson et al. | Determination of serum or plasma glucose on the" AutoAnalyzer II" by use of the hexokinase reaction | |
| Li et al. | Vitreous humor: A review of biochemical constituents in postmortem interval estimation | |
| CN113358733B (en) | Method for detecting new biosynthesis pathway in cell | |
| Chew et al. | Stable isotopes in avian research: a step by step protocol to feather sample preparation for stable isotope analysis of carbon (δ13C), nitrogen (δ15N), and hydrogen (δ2H). Version 1.1 | |
| CN101799462A (en) | Method for quantitative evaluation of drug effect by applying metabonomic technology | |
| Da Silva et al. | Simultaneous determination of pH, chloride and nickel in electroplating baths using sequential injection analysis | |
| Abramova et al. | Integrated multi-sensor chip with photocured polymer membranes containing copolymerised plasticizer for direct pH, potassium, sodium and chloride ions determination in blood serum | |
| CN102539352A (en) | Determination method of cyanogen in thiocyanate | |
| Omar | Essential laboratory knowledge for the clinician | |
| CN102242181A (en) | Flue gas condensate cytotoxicity determination method based on cell electronic sensor | |
| CN113390666B (en) | Method for detecting performance index of chemical substance in cell | |
| Matsubara et al. | Determination of reference intervals for 26 commonly measured biochemical analytes with consideration of long-term within-individual variation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20220112 Address after: 230000 96 Jinzhai Road, Hefei City, Anhui Province Applicant after: University of Science and Technology of China Applicant after: Xiong Wei Applicant after: Liu Dan Applicant after: Zhang Xuehe Address before: 230000 96 Jinzhai Road, Hefei City, Anhui Province Applicant before: University of Science and Technology of China |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20221220 Address after: Room 306, Building 11, Lingshuiyuan South, Shuiyangjiang Road, Baohe District, Hefei City, Anhui Province, 230000 Applicant after: Xiong Wei Applicant after: Liu Dan Applicant after: Zhang Xuehe Address before: 230000 96 Jinzhai Road, Hefei City, Anhui Province Applicant before: University of Science and Technology of China Applicant before: Xiong Wei Applicant before: Liu Dan Applicant before: Zhang Xuehe Effective date of registration: 20221220 Address after: 401, Building B3, Zhong'an Chuanggu Science Park, No. 900, Wangjiang West Road, High tech Zone, Hefei City, Anhui Province, 230000 Applicant after: Anhui Kecheng Intelligent Health Technology Co.,Ltd. Address before: Room 306, Building 11, Lingshuiyuan South, Shuiyangjiang Road, Baohe District, Hefei City, Anhui Province, 230000 Applicant before: Xiong Wei Applicant before: Liu Dan Applicant before: Zhang Xuehe |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |